New Corporation an up-and-coming biotech company, provides the following selected financial statement information. Financial information for Benchmark Corporation a well-established biotech company whose financial ratios represent the gold-standard in the industry, is also provided. New Cor tion Benchmark rporation 2024 2023 2024 2023 Cash and cash equivalents $350,656 $238,446 $4,207,872 $3,997,478 Short-term investments 490,545 353,192 9,320,355 8,947,541 Accounts receivable 32,588 23,137 782,112 766,470 Property, plant and equipment 852,459 588,197 18,754,098 17,816,393 Intangible assets 2,565,875 1,796,113 41,054,000 39,822,380 Long-term investments 1,545,856 1,082,099 46,375,680 45,448,166 Total asset 5,837,979 4,081,184 120,494,117 116,798,428 Total li